Posted on: 05 August, 2024
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team.
The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia.
This form of blood cancer is particularly aggressive, with less .....
Read more
Category: Funding support, Research Excellence
Posted on: 31 July, 2024
A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury.
The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are over 20,000 people living with the injury......
Read more
Category: Neuroscience and Pain Research, Research Excellence
Posted on: 15 July, 2024
In a sign of the strength of the Kolling Institute’s research and clinical capabilities, Professor Trudy Rebbeck has been awarded a $2.5 million grant to offer a musculoskeletal care program in rural and remote parts of Australia.
As a Professor of Allied Health and a physiotherapist, Trudy will lead the collaborative project involving University of Sydney, NSLHD and Kolling Institute researchers M.....
Read more
Category: Funding support, Musculoskeletal Research, Neuroscience and Pain Research, New Treatment
Posted on: 05 July, 2024
A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes.
The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due to peripheral arterial disease.
Alarmingly, an estimated eight p.....
Read more
Category: Research Excellence
Posted on: 01 July, 2024
While there has been a great deal of encouraging progress with many cancer treatments over the last decade, the prognosis for people with acute myeloid leukaemia remains dismal, with only 27 per cent of patients surviving more than five years after treatment.
Lead researcher Dr Jenny Wang said we have seen a sharp rise in the number of people with the deadly form of blood cancer in recent years and.....
Read more
Category: Funding support, Research Excellence
Posted on: 26 June, 2024
Here's a snapshot of our latest research at the Kolling Institute and the impact it's having across the community, from new national guidelines for physios helping those with life-changing spinal cord injuries to a new approach for those with debilitating chronic pain. There's a focus too on our researchers reducing the physical toll of spaceflight and the latest care for osteoarthritis.
Flip.....
Read more
Category: Newsletters
Posted on: 24 June, 2024
It is with great sadness that the Kolling Institute acknowledges the passing of Professor John Walsh AO.
Professor Walsh had a longstanding relationship with many researchers across the Kolling and the local health district and was immensely respected by his colleagues.
Having a background as an actuary, Professor Walsh applied his expertise to many projects over his life, specifically policy devel.....
Read more
Category: Research Excellence
Posted on: 29 May, 2024
Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prestigious Boston Marathon while raising significant funds for cancer research.
Gemma crossed the finish line in a sub four hour time as part of the talented team running for the internationally renowned Dana Farber Cancer Institute.
Gemma ran her first marathon just after completing six months of chemot.....
Read more
Category: Cardiovascular and Renal Research, Funding support, Research Excellence
Posted on: 23 May, 2024
Leading researchers from the Kolling Institute have welcomed the opportunity to collaborate with Metakosmos as it pioneers the development of a next-generation space suit.
Led by CEO Kiriti Rambhatla, Metakosmos is working to revolutionise human spaceflight technology. Their Kosmosuit architecture has garnered acclaim and the interest of the Kolling Institute’s Academic Director Professor James Ell.....
Read more
Category: Musculoskeletal Research, Research Excellence, World-leading technology
Posted on: 10 May, 2024
We would like to congratulate our early career researcher Dr Nashwa Masnoon from the Kolling’s Ageing and Pharmacology Lab who has taken out the ATA Scientific Young Scientist Encouragement Award.
Nashwa, who is a postdoctoral research pharmacist, clinched the $1500 prize for her assessment of the risks and benefits of using artificial intelligence in research.
The award will enable her to attend a.....
Read more
Category: Awards, Neuroscience and Pain Research, Research Excellence